Form NPORT-P HARTFORD SERIES FUND For: Mar 31
Tweet
Share
E-mailGet inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
http://archive.fast-edgar.com/20220525/AO22EG2DZC229ZZZ2X2V2ZOHTNDPEQ22Z242 Filed on: May 25, 2022
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Inmagene and HUTCHMED Announce First Participants in Global Phase I Trial of IMG-007
- Boehringer Ingelheim, Evotec and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance
- ClearMind Biomedical Clears FIM Clinical Trial for Least Invasive ICH Treatment to Date
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
